Earum Pharmaceuticals Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 876,000 (47%) | — | ₹315 Cr |
| Retail | — | 876,000 (47%) | — | ₹315 Cr |
| Market Maker | — | 96,000 (5%) | — | ₹3 Cr |
| Σ Total | — | 1,848,000 (100%) | — | ₹6,653 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹108,000 |
| Retail (Max) | 13 | 39,000 | ₹1,404,000 |
| S-HNI (Min) | 14 | 42,000 | ₹1,512,000 |
| B-HNI (Min) | 67 | 201,000 | ₹7,236,000 |
Financial Statements Amount in Lakhs
| Metric | 31-Dec-18 | 31-Mar-18 | 31-Dec-17 |
|---|---|---|---|
| Revenue | 3,450 | 3,544 | 2,334 |
| Profit After Tax | 87 | 86 | 16 |
| Total Assets | 2,741 | 2,053 | 1,108 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Working Capital requirement – 5.00
- 2 General Corporate Purpose – 0.86
- 3 To meet Issue Expenses – 0.79
Company Overview
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in trading, marketing, distribution of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynaecology drugs, steroids, anti-biotic drugs, cerebral activator drugs, gastrointestinal drugs, etc.
The company is also involved in the trading business of active pharmaceutical ingredients (API's) including Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP and Albendazole IP. Earum Pharmaceuticals is primarily engaged in two types of business activities; marketing of its own formulations products and trading of other brands' generic formulations. Currently, it has around 24 products which are manufactured by 3rd parties and marketed by the company under its brand name.
It has a warehouse at Ahmedabad, Gujarat equipped with all amenities to process business operations smoothly. The company has a domestic and international presence across South East Asia, Latin America and Africa.
Future goals of Earum Pharmaceuticals Ltd are:
1. Make global presence more prominent
2. Enhance customer satisfaction by improving market skills
3. Deal in quality standard products
The competitive strengths of the company are:
1. Wide product range
2. The experienced promoter of 11+ years experience
3. Quality assurance